Opportunity ID: 347176

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-23-022
Funding Opportunity Title: Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 28, 2023
Last Updated Date: Mar 28, 2023
Original Closing Date for Applications: Aug 25, 2023
Current Closing Date for Applications: Aug 25, 2023
Archive Date: Sep 30, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Special district governments
Independent school districts
Public housing authorities/Indian housing authorities
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
State governments
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages research focused on the development of convenient small animal models that will support infection and replication of HBV and/or HCV, ideally leading to the dichotomous outcomes of clearance and persistence. Alternatively, closely related surrogate virus-host systems or robust xenotransplantation models dually engrafted with human liver cells and human immune systems can be developed.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-022.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 347176 Full Announcement-RFA-AI-23-022 -> RFA-AI-23-022-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00280859 Jul 25, 2023 Aug 25, 2023 View

Package 1

Mandatory forms

347176 RR_SF424_5_0-5.0.pdf

347176 PHS398_CoverPageSupplement_5_0-5.0.pdf

347176 RR_OtherProjectInfo_1_4-1.4.pdf

347176 PerformanceSite_4_0-4.0.pdf

347176 RR_KeyPersonExpanded_4_0-4.0.pdf

347176 PHS398_ResearchPlan_5_0-5.0.pdf

347176 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

347176 RR_Budget_3_0-3.0.pdf

347176 RR_SubawardBudget30_3_0-3.0.pdf

347176 PHS398_ModularBudget_1_2-1.2.pdf

347176 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T14:14:14-05:00

Share This Post, Choose Your Platform!

About the Author: